Jump to content

Talk:Rigaku

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

Update Revenue using current information

[edit]

Issue: information is two years out of date

Existing: Revenue: “¥ 63 billion (FY 2022) (US $420 million)” Change to: Revenue: "¥ 90.65 billion (FY 2024) (≈ US $600 million)”

Key Sources: StockAnalysis revenue page shows ¥ 90.65 bn for FY 2024 (stockanalysis.com) Investing.com LTM revenue 90.652 bn (in.investing.com) https://rigaku-holdings.com/english/ir/performance/ BeverlyVincent30 (talk) 21:27, 17 June 2025 (UTC)[reply]

Request to update number of employees

[edit]


  • 'Employees: 1,800 (2022):
  • Out of date by two years. Current info: 1,867 (as of 31 Dec 2024):
  • StockAnalysis employee statistic lists 1,867 on 31 Dec 2024 [1]):

BeverlyVincent30 (talk) 13:38, 18 June 2025 (UTC)[reply]

References

 Note: The source presented isn't very reliable, and there's the added point that these numbers do fluctuate wildly and are therefore not really relevant in a meaningful way. Historical trends are a more accurate employee representation. I won't decline the request, but just something to bear in mind. PK650 (talk) 21:18, 21 June 2025 (UTC)[reply]

Request to update company history with information about IPO

[edit]


  • History → 2021 Carlyle deal: Carlyle … agreed to jointly acquire …:
  • Deal completed; ownership details known; IPO followed.:
  • Recommended replacement: 2021 – Carlyle and founder Hikaru Shimura completed the acquisition, with Carlyle holding ~80 %. 2024 – Rigaku Holdings listed on TSE Prime (ticker 268A) on 25 Oct."
  • Carlyle press release on acquisition (80 %) ([1])
  • Carlyle press release on TSE listing ([2])
  • Reuters IPO pricing article (raised ¥129 bn) ([3]):

BeverlyVincent30 (talk) 13:43, 18 June 2025 (UTC)[reply]

Request to update total revenue to more recent value

[edit]


  • Revenue: ¥ 63 billion (FY 2022) (US $420 million) should be changed to ¥ 90.65 billion (FY 2024) (≈ US $600 million):
  • Two years out of date:
  • StockAnalysis revenue page shows ¥ 90.65 bn for FY 2024 [1]:

BeverlyVincent30 (talk) 13:47, 18 June 2025 (UTC)[reply]

Request to add IPO as a milestone to company history

[edit]


  • Add bullet: 2024 – Raised ¥129 bn (US $863 m) in Tokyo IPO; trading began 25 Oct:
  • IPO is a major company milestone:
  • Reuters market-debut story [1]:
  • Reuters IPO pricing story [2]:

BeverlyVincent30 (talk) 14:04, 18 June 2025 (UTC)[reply]

Request to add date to CEO appointment

[edit]


  • Add appointment date to Jun Kawakami: (appointed Feb 2023):
  • Adds context:
  • ChemEurope coverage [1]:

BeverlyVincent30 (talk) 14:32, 18 June 2025 (UTC)[reply]

Add missing location to Locations section

[edit]


  • Add to Locations: Rigaku BioScience Lab (Cambridge, MA):
  • Update missing information:
  • MassBio Member news [1]:
  • Analytica World [2]

BeverlyVincent30 (talk) 14:41, 18 June 2025 (UTC)[reply]

Request to update product paragraph

[edit]


  • Product list change to: Rigaku manufactures and supplies scientific instrumentation to academia, industry and trade. These include X-ray diffractometers, single crystal diffractometers, X-ray imagers, X-ray fluorescence spectrometers (both Energy Dispersive and Wavelength Dispersive varieties), semiconductor metrology instruments, thermal analysis equipment, handheld Raman analyzers, X-ray and EUV optics, X-ray sources and X-ray detectors.:
  • List is frozen at 2022:
  • Global website [1]:

BeverlyVincent30 (talk) 14:48, 18 June 2025 (UTC)[reply]